Prima BioMed Ltd (IMMP) vs 4D pharma PLC Sponsored ADR (LBPS)

Prima BioMed Ltd and 4D pharma PLC Sponsored ADR are both Biotechnology companies. Prima BioMed Ltd and 4D pharma PLC Sponsored ADR are of similar size ($38.5M and $37.2M). Across the 11 metrics below, Prima BioMed Ltd leads on 7 and 4D pharma PLC Sponsored ADR on 4.

Valuation

Metric IMMP LBPS Biotechnology median
P/E n/m n/m 7.88
P/S n/m 211.23 11.47
P/B 0.49 9.49 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m 205.89 10.73
Earnings yield (40.42%) (40.76%) (28.84%)
Free cash flow yield (181.72%) (30.32%) (23.03%)

Profitability

Metric IMMP LBPS Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin — 0.00% 0.00%
Net margin — (9,577.06%) 0.00%
Free cash flow margin 0.00% (6,318.73%) 0.00%
Return on equity 0.00% (742.15%) (57.72%)
Return on assets 0.00% (371.23%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric IMMP LBPS Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) (37.04%) 35.04% —
Revenue growth, 5-year CAGR 40.79% 21.70% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IMMP LBPS Biotechnology median
Debt to equity 0.01 0.43 0.00
Current ratio 2.97 5.21 4.73
Net debt to EBITDA 0.92 0.23 0.96

Dividend

Metric IMMP LBPS Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric IMMP LBPS Biotechnology median
Market cap 38.48m 37.19m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack